Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Jun. 30, 2022
Current assets:    
Cash $ 26,661 $ 280,877
Accounts receivable (net of allowance of $0 and $0, respectively) 53,631 93,674
Inventory 395,521 331,531
Other current asset 92,876 137,797
Total current assets 568,689 843,879
Total assets 568,689 843,879
Current liabilities:    
Accounts payable 533,568 234,152
Accrued expense - related party 88,676
Convertible notes payable - net of discounts 590,614 344,151
Note payable, net of discount 264,500
Total current liabilities 1,477,358 578,303
Commitments and contingencies
Stockholders’ equity:    
Series A Preferred Stock, ($0.001 par value, 1,000,000 shares authorized, and 1,000 issued and outstanding as of March 31, 2023 and June 30, 2021, respectively) 1 1
Series B Preferred Stock, ($0.001 par value, 5,000 shares authorized, and 1,950 and 3,260 issued and outstanding as of March 31, 2023 and June 30, 20221, respectively) 2 3
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 114,050,840 issued and outstanding as of March 31, 2023 and 91,814,484 issued and outstanding as of June 30, 2022, respectively) 114,051 91,814
Additional paid in capital 32,982,728 28,275,216
Deferred compensation (8,000)
Accumulated deficit (33,997,451) (28,101,458)
Total Stockholders’ Equity (908,669) 265,576
Total Liabilities and Stockholders’ Equity $ 568,689 $ 843,879